LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 3 of 166
Next
>>
>
51 to 75 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Relative Growth Rate After Treatment
BT-20	GSK1059615	0.04	uM	LJP5	72	hr	1334	4146	3970	1.0441	1.0664
BT-20	GSK1059615	0.04	uM	LJP6	72	hr	1334	3858	3970	0.9717	0.9573
BT-20	GSK1904529A	0.04	uM	LJP6	72	hr	1334	3236	3970	0.8149	0.7212
BT-20	Omipalisib	0.04	uM	LJP6	72	hr	1334	1179	3970	0.2970	-0.0589
BT-20	GSK 690693	0.04	uM	LJP5	72	hr	1334	3452	3970	0.8693	0.8032
BT-20	GW843682X	0.04	uM	LJP6	72	hr	1334	3587	3970	0.9034	0.8545
BT-20	HG-5-113-01	0.04	uM	LJP5	72	hr	1334	3806	3970	0.9585	0.9374
BT-20	HG-5-88-01	0.04	uM	LJP6	72	hr	1334	2936	3970	0.7395	0.6077
BT-20	Imatinib	0.04	uM	LJP6	72	hr	1334	3830	3970	0.9647	0.9468
BT-20	JNK-9L	0.04	uM	LJP6	72	hr	1334	3521	3970	0.8867	0.8293
BT-20	JW-7-24-1	0.04	uM	LJP6	72	hr	1334	3217	3970	0.8101	0.7140
BT-20	Lapatinib	0.04	uM	LJP6	72	hr	1334	3647	3970	0.9184	0.8771
BT-20	LDN-193189	0.04	uM	LJP5	72	hr	1334	4142	3970	1.0431	1.0649
BT-20	Linifanib	0.04	uM	LJP6	72	hr	1334	4189	3970	1.0551	1.0830
BT-20	Linsitinib	0.04	uM	LJP5	72	hr	1334	3462	3970	0.8718	0.8070
BT-20	Mitoxantrone	0.04	uM	LJP5	72	hr	1334	1575	3970	0.3966	0.0912
BT-20	Mitoxantrone	0.04	uM	LJP6	72	hr	1334	2227	3970	0.5608	0.3385
BT-20	MK2206	0.04	uM	LJP6	72	hr	1334	4075	3970	1.0262	1.0395
BT-20	Neratinib	0.04	uM	LJP5	72	hr	1334	3101	3970	0.7811	0.6703
BT-20	Nilotinib	0.04	uM	LJP5	72	hr	1334	4101	3970	1.0329	1.0496
BT-20	Nintedanib	0.04	uM	LJP6	72	hr	1334	4047	3970	1.0193	1.0291
BT-20	NU7441	0.04	uM	LJP5	72	hr	1334	4239	3970	1.0675	1.1017
BT-20	Dactolisib	0.04	uM	LJP5	72	hr	1334	1982	3970	0.4991	0.2456
BT-20	NVP-TAE684	0.04	uM	LJP6	72	hr	1334	4079	3970	1.0272	1.0410
BT-20	Palbociclib	0.04	uM	LJP6	72	hr	1334	3045	3970	0.7668	0.6488

|<
<<
Previous
Page 3 of 166
Next
>>
>
51 to 75 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)